IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients

Detalhes bibliográficos
Autor(a) principal: Bacci,M.R.
Data de Publicação: 2015
Outros Autores: Leme,R.C.P., Zing,N.P.C., Murad,N., Adami,F., Hinnig,P.F., Feder,D., Chagas,A.C.P., Fonseca,F.L.A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500427
Resumo: Community-acquired pneumonia (CAP) is amongst the leading causes of death worldwide. As inflammatory markers, cytokines can predict outcomes, if interpreted together with clinical data and scoring systems such as CURB-65, CRB, and Acute Physiology and Chronic Health Evaluation II (APACHE II). The aim of this study was to determine the impact of inflammatory biomarkers on the early mortality of hospitalized CAP patients. Twenty-seven CAP patients needing hospitalization were enrolled for the study and samples of interleukin-1 (IL-1) and interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP), and homocystein were collected at the time of admission (day 1) as well as on the seventh day of the treatment. There was a significant reduction in the levels of IL-6 between the first and the second collections. Median IL-6 values decreased from 24 pg/mL (day 1) to 8 pg/mL (day 7) (P=0.016). The median levels of TNF-α were higher in patients: i) with acute kidney injury (AKI) (P=0.045), ii) requiring mechanical ventilation (P=0.040), iii) with short hospital stays (P=0.009), iv) admitted to the intensive care unit (ICU) (P=0.040), v) who died early (P=0.003), and vi) with worse CRB scores (P=0.013). In summary, IL-6 and TNF-α levels were associated with early mortality of CAP patients. Longer admission levels demonstrated greater likelihood of early death and overall mortality, necessity of mechanical ventilation, and AKI.
id ABDC-1_7d21fdf52555cc9dd3e7cc97fed1b35d
oai_identifier_str oai:scielo:S0100-879X2015000500427
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patientsCommunity acquired pneumoniaInterleukin-6Tumor necrosis factor αSepsisCommunity-acquired pneumonia (CAP) is amongst the leading causes of death worldwide. As inflammatory markers, cytokines can predict outcomes, if interpreted together with clinical data and scoring systems such as CURB-65, CRB, and Acute Physiology and Chronic Health Evaluation II (APACHE II). The aim of this study was to determine the impact of inflammatory biomarkers on the early mortality of hospitalized CAP patients. Twenty-seven CAP patients needing hospitalization were enrolled for the study and samples of interleukin-1 (IL-1) and interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP), and homocystein were collected at the time of admission (day 1) as well as on the seventh day of the treatment. There was a significant reduction in the levels of IL-6 between the first and the second collections. Median IL-6 values decreased from 24 pg/mL (day 1) to 8 pg/mL (day 7) (P=0.016). The median levels of TNF-α were higher in patients: i) with acute kidney injury (AKI) (P=0.045), ii) requiring mechanical ventilation (P=0.040), iii) with short hospital stays (P=0.009), iv) admitted to the intensive care unit (ICU) (P=0.040), v) who died early (P=0.003), and vi) with worse CRB scores (P=0.013). In summary, IL-6 and TNF-α levels were associated with early mortality of CAP patients. Longer admission levels demonstrated greater likelihood of early death and overall mortality, necessity of mechanical ventilation, and AKI.Associação Brasileira de Divulgação Científica2015-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500427Brazilian Journal of Medical and Biological Research v.48 n.5 2015reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20144402info:eu-repo/semantics/openAccessBacci,M.R.Leme,R.C.P.Zing,N.P.C.Murad,N.Adami,F.Hinnig,P.F.Feder,D.Chagas,A.C.P.Fonseca,F.L.A.eng2019-03-19T00:00:00Zoai:scielo:S0100-879X2015000500427Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-03-19T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
title IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
spellingShingle IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
Bacci,M.R.
Community acquired pneumonia
Interleukin-6
Tumor necrosis factor α
Sepsis
title_short IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
title_full IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
title_fullStr IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
title_full_unstemmed IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
title_sort IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
author Bacci,M.R.
author_facet Bacci,M.R.
Leme,R.C.P.
Zing,N.P.C.
Murad,N.
Adami,F.
Hinnig,P.F.
Feder,D.
Chagas,A.C.P.
Fonseca,F.L.A.
author_role author
author2 Leme,R.C.P.
Zing,N.P.C.
Murad,N.
Adami,F.
Hinnig,P.F.
Feder,D.
Chagas,A.C.P.
Fonseca,F.L.A.
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bacci,M.R.
Leme,R.C.P.
Zing,N.P.C.
Murad,N.
Adami,F.
Hinnig,P.F.
Feder,D.
Chagas,A.C.P.
Fonseca,F.L.A.
dc.subject.por.fl_str_mv Community acquired pneumonia
Interleukin-6
Tumor necrosis factor α
Sepsis
topic Community acquired pneumonia
Interleukin-6
Tumor necrosis factor α
Sepsis
description Community-acquired pneumonia (CAP) is amongst the leading causes of death worldwide. As inflammatory markers, cytokines can predict outcomes, if interpreted together with clinical data and scoring systems such as CURB-65, CRB, and Acute Physiology and Chronic Health Evaluation II (APACHE II). The aim of this study was to determine the impact of inflammatory biomarkers on the early mortality of hospitalized CAP patients. Twenty-seven CAP patients needing hospitalization were enrolled for the study and samples of interleukin-1 (IL-1) and interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP), and homocystein were collected at the time of admission (day 1) as well as on the seventh day of the treatment. There was a significant reduction in the levels of IL-6 between the first and the second collections. Median IL-6 values decreased from 24 pg/mL (day 1) to 8 pg/mL (day 7) (P=0.016). The median levels of TNF-α were higher in patients: i) with acute kidney injury (AKI) (P=0.045), ii) requiring mechanical ventilation (P=0.040), iii) with short hospital stays (P=0.009), iv) admitted to the intensive care unit (ICU) (P=0.040), v) who died early (P=0.003), and vi) with worse CRB scores (P=0.013). In summary, IL-6 and TNF-α levels were associated with early mortality of CAP patients. Longer admission levels demonstrated greater likelihood of early death and overall mortality, necessity of mechanical ventilation, and AKI.
publishDate 2015
dc.date.none.fl_str_mv 2015-05-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500427
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500427
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20144402
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.48 n.5 2015
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302944550846464